Study To Evaluate Treating Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis Patients



Status:Archived
Conditions:Cardiology, Neurology, Multiple Sclerosis
Therapuetic Areas:Cardiology / Vascular Diseases, Neurology, Other
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:August 2010
End Date:September 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Utility of Chronic Cerebrospinal Venous Insufficiency Percutaneous Angioplasty for Multiple Sclerosis: The Albany Vascular Group Study


This is a single center, multispecialty, randomized double blind placebo control feasibility
clinical trial. The purpose is to evaluate the safety, feasibility and efficacy of
percutaneous transluminal angioplasty in treating extracranial venous obstructive lesions,
and its influence on the clinical outcomes of Multiple Sclerosis (MS) patients that have
been found to have chronic cerebrospinal venous insufficiency (CCSVI).



We found this trial at
1
site
The Vascular Group, PLLC
Albany, New York 12205
?
mi
from
Albany, NY
Click here to add this to my saved trials